• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药物错误导致甲氨蝶呤引起的全血细胞减少和黏膜炎。

Methotrexate-Induced Pancytopenia and Mucositis Caused by Medication Error.

机构信息

University of Ghana Medical School, Department of Medicine and Therapeutics, Accra, Ghana.

Korle Bu Teaching Hospital, Department of Medicine and Therapeutics, Accra, Ghana.

出版信息

Ghana Med J. 2020 Mar;54(1):68-71. doi: 10.4314/gmj.v54i1.10.

DOI:10.4314/gmj.v54i1.10
PMID:32863415
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7445697/
Abstract

UNLABELLED

The use of methotrexate in routine clinical practice is becoming more common among specialties such as rheumatology, dermatology, oncology and obstetrics. General clinicians are increasingly encountering patients on this drug. Though it has a high safety profile, there is a recognised risk of acute toxicity or long-term complications associated with its use, which can be worsened by several factors such as advanced age, moderate to severe renal impairment, low folate level and/or inadequate folate supplementation, hypoalbuminaemia, polypharmacy causing drug-drug interactions and wrongful administration. We present a case of a 45-year old woman with rheumatoid arthritis who presented with acute pancytopaenia and mucositis due to methotrexate toxicity. We highlight its peculiar dosing regimen to minimise prescribing errors.

FUNDING

None.

摘要

背景

甲氨蝶呤在风湿科、皮肤科、肿瘤科和妇产科等专业领域的常规临床实践中应用越来越多。普通临床医生越来越多地遇到使用该药的患者。尽管甲氨蝶呤安全性高,但已知其使用存在急性毒性或长期并发症的风险,这些风险可因多种因素而加重,如高龄、中重度肾功能不全、叶酸水平低和/或叶酸补充不足、低白蛋白血症、药物相互作用导致的多种药物并用和错误给药。我们报告了 1 例 45 岁类风湿关节炎女性患者,因甲氨蝶呤毒性出现全血细胞减少和黏膜炎。我们强调了其特殊的给药方案,以尽量减少处方错误。

资金

无。

相似文献

1
Methotrexate-Induced Pancytopenia and Mucositis Caused by Medication Error.药物错误导致甲氨蝶呤引起的全血细胞减少和黏膜炎。
Ghana Med J. 2020 Mar;54(1):68-71. doi: 10.4314/gmj.v54i1.10.
2
Pancytopenia after accidental overdose of methotrexate. A complication of low-dose therapy for rheumatoid arthritis.甲氨蝶呤意外过量后全血细胞减少。类风湿关节炎低剂量治疗的一种并发症。
Med J Aust. 1991 Oct 7;155(7):493-4. doi: 10.5694/j.1326-5377.1991.tb93850.x.
3
Methotrexate-induced Severe Pancytopenia in a Patient with Rheumatoid Arthritis: A Case Report and Review of Literature.甲氨蝶呤致类风湿关节炎患者严重全血细胞减少:病例报告及文献复习。
Curr Drug Saf. 2024;19(2):224-235. doi: 10.2174/1574886318666230516115737.
4
Methotrexate-induced pancytopenia: a case series of 46 patients.甲氨蝶呤所致全血细胞减少症:46例病例系列
Int J Rheum Dis. 2017 Jul;20(7):846-851. doi: 10.1111/1756-185X.13004. Epub 2017 Mar 5.
5
Methotrexate-induced pancytopenia: serious and under-reported? Our experience of 25 cases in 5 years.甲氨蝶呤所致全血细胞减少症:严重但报告不足?我们5年里25例病例的经验。
Rheumatology (Oxford). 2005 Aug;44(8):1051-5. doi: 10.1093/rheumatology/keh685. Epub 2005 May 18.
6
Shingles: More than Meets the Eye.带状疱疹:不止于表面所见
Folia Med (Plovdiv). 2019 Mar 1;61(1):158-162. doi: 10.2478/folmed-2018-0046.
7
Methotrexate-associated, early-onset pancytopenia in rheumatoid arthritis.类风湿关节炎中与甲氨蝶呤相关的早发性全血细胞减少症。
Arch Intern Med. 1989 Jun;149(6):1430-1.
8
Pancytopenia secondary to methotrexate therapy in rheumatoid arthritis.类风湿关节炎患者甲氨蝶呤治疗继发全血细胞减少
Arthritis Rheum. 1996 Feb;39(2):272-6. doi: 10.1002/art.1780390214.
9
[Pancytopenia during low-dosage methotrexate treatment in patients with rheumatoid arthritis].[类风湿关节炎患者低剂量甲氨蝶呤治疗期间的全血细胞减少症]
Tidsskr Nor Laegeforen. 1993 Sep 20;113(22):2805-7.
10
Severe pancytopenia in a patient taking low dose methotrexate and probenecid.一名正在服用低剂量甲氨蝶呤和丙磺舒的患者出现严重全血细胞减少。
J Rheumatol. 1991 Apr;18(4):609-10.

引用本文的文献

1
A Fatal Fate: A Medical Error Leading to Acute Methotrexate Toxicity.致命的结局:导致急性甲氨蝶呤中毒的医疗差错
Cureus. 2022 Oct 25;14(10):e30659. doi: 10.7759/cureus.30659. eCollection 2022 Oct.
2
Effect and Mechanism of siRNAs Targeting IL-1β/TNF-α Combined with BMSCs Transplantation in Ameliorating Rheumatoid Arthritis in Rats.靶向IL-1β/TNF-α的小干扰RNA联合骨髓间充质干细胞移植对改善大鼠类风湿性关节炎的作用及机制
Vet Sci. 2022 Sep 28;9(10):531. doi: 10.3390/vetsci9100531.
3
Methotrexate-Induced Septicemia With Severe Pancytopenia and Diffuse Cutaneous Ulcerative Lesions.甲氨蝶呤诱发的败血症伴严重全血细胞减少和弥漫性皮肤溃疡性病变
Cureus. 2021 Sep 17;13(9):e18069. doi: 10.7759/cureus.18069. eCollection 2021 Sep.

本文引用的文献

1
BSR and BHPR guideline for the prescription and monitoring of non-biologic disease-modifying anti-rheumatic drugs.英国风湿病学会(BSR)和英国国家卫生与临床优化研究所(BHPR)关于非生物改善病情抗风湿药处方及监测的指南
Rheumatology (Oxford). 2017 Jun 1;56(6):865-868. doi: 10.1093/rheumatology/kew479.
2
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update.EULAR 推荐的类风湿关节炎治疗策略:2016 年更新版
Ann Rheum Dis. 2017 Jun;76(6):960-977. doi: 10.1136/annrheumdis-2016-210715. Epub 2017 Mar 6.
3
Methotrexate-induced pancytopenia: a case series of 46 patients.甲氨蝶呤所致全血细胞减少症:46例病例系列
Int J Rheum Dis. 2017 Jul;20(7):846-851. doi: 10.1111/1756-185X.13004. Epub 2017 Mar 5.
4
2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis.2015年美国风湿病学会类风湿关节炎治疗指南
Arthritis Care Res (Hoboken). 2016 Jan;68(1):1-25. doi: 10.1002/acr.22783. Epub 2015 Nov 6.
5
Pharmacokinetic drug-drug interactions with methotrexate in oncology.肿瘤患者的甲氨蝶呤药代动力学药物相互作用。
Expert Rev Clin Pharmacol. 2011 Nov;4(6):743-50. doi: 10.1586/ecp.11.57.
6
Delayed elimination of methotrexate associated with co-administration of proton pump inhibitors.甲氨蝶呤与质子泵抑制剂联合应用导致其消除延迟。
Anticancer Res. 2010 Sep;30(9):3807-10.
7
Methotrexate drug interactions in the treatment of rheumatoid arthritis: a systematic review.甲氨蝶呤治疗类风湿关节炎的药物相互作用:系统评价。
J Rheumatol. 2010 Jul;37(7):1416-21. doi: 10.3899/jrheum.090153. Epub 2010 May 1.
8
Long-term safety of methotrexate monotherapy in patients with rheumatoid arthritis: a systematic literature research.甲氨蝶呤单药治疗类风湿关节炎患者的长期安全性:一项系统文献研究
Ann Rheum Dis. 2009 Jul;68(7):1100-4. doi: 10.1136/ard.2008.093690. Epub 2008 Dec 5.
9
Pancytopenia induced by low-dose methotrexate. A study of the cases reported to the Finnish Adverse Drug Reaction Register From 1991 to 1999.低剂量甲氨蝶呤所致全血细胞减少症。对1991年至1999年向芬兰药物不良反应登记处报告的病例的研究。
Scand J Rheumatol. 2005 May-Jun;34(3):238-41. doi: 10.1080/03009740510018570.
10
Methotrexate-induced pancytopenia: serious and under-reported? Our experience of 25 cases in 5 years.甲氨蝶呤所致全血细胞减少症:严重但报告不足?我们5年里25例病例的经验。
Rheumatology (Oxford). 2005 Aug;44(8):1051-5. doi: 10.1093/rheumatology/keh685. Epub 2005 May 18.